Browse > Article

Screening of Herbal Medicines from China with Inhibitory Activity on Advanced Glycation End Products (AGEs) Formation (V)  

Kim, Young-Sook (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Choi, Sung-Hoon (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Kim, Joo-Hwan (Department of Life Science, Kyungwon University)
Kim, Jin-Sook (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Publication Information
Korean Journal of Pharmacognosy / v.42, no.1, 2011 , pp. 46-53 More about this Journal
Abstract
Advanced glycation end products (AGEs) have been postulated to play a central role in the development of diabetic complications. A variety of different agents that inhibit AGEs have been under investigation. In this study, 66 herbal medicines from China have been investigated with an in vitro evaluation system using AGEs formation inhibitory activity. Of these, 31 herbal medicines ($IC_{50}$ < $50\;{\mu}g/ml$) were found to have significant AGEs formation inhibitory activity. Particularly, 5 herbal medicines, Camptotheca acuminata (branches and leaves), Quercus franchetii (branches), Camellia pitardii (leaves, branches, and fruits), Antidesma bunius (whole plants), and Loranthus parasiticus (whole plants) showed more potent inhibitory activity (approximately 6-20 fold) than the positive control aminoguanidine ($IC_{50}=52.96\;{\mu}g/ml$).
Keywords
Advanced glycation end products (AGEs); Diabetic complications; Herbal medicines;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Cha, E. E., Kim, B. S., Kim, D. H., Lee, Y. K., Kim, Y. J. and Kang, J. S. (2003) Study on antioxidant action of Loranthus parasiticus (L) merr. Korean. J. Oriental Physiol. Pathol. 17: 939-945.
2 Sohn, S. H., Lee, H. J., Nam, J. Y., Kim, S. H., Jung, H. J., Kim, Y. S., Shin, M. K., Hong, M. C. and Bae. H. S. (2009) Screening of herbal medicines for the recovery of cispaltininduced nephrotoxicity. Environ. Toxicol. Pharmacol. 28: 206-212.   DOI   ScienceOn
3 Jung, S.-J., Lee, J. H., Song, H. N., Seong, N. S., Lee, S. E. and Baek, N. I. (2004) Screening for antioxidant activity of plant medicinal extracts. J. Korean Soc. Appl. Biol. Chem. 47: 135-140.
4 Butkhup, L. and Samappito, S. (2008) An analysis on flavonoids contents in mao luang fruits of fifteen cultivars (Antidesma bunius), grown in northeast Thailand. Pak. J. Biol. Sci. 11: 996-1002.   DOI   ScienceOn
5 Jang, D. S., Lee, G. Y., Lee, Y. M., Kim, Y. S., Sun, H., Kim, D. H. and Kim, J. S. (2009) Flavan-3-ols having a ${\gamma}-lactam$ from the roots of Actinidia arguta inhibit the formation of advanced glycation end products in vitro. Chem. Pharm. Bull. 57: 397-400.   DOI   ScienceOn
6 Huebschmann, A. G., Vlassara, H., Regensteiner, J. G. and Reusch, J. (2006) Diabetes and advanced glycoxidation end products. Diabetes care 29: 1420-1432.   DOI   ScienceOn
7 Kim, Y. S., Lee, Y. M., Kim, C. -S., Sohn, E. J., Jang, D. S. and Kim, J. S. (2006) Inhibitory effect of KIOM, a new herbal prescription, on AGEs formation and expression of type IV collagen and $TGF-{\beta}1$ in STZ-induced diabetic rats. Kor. J. Pharmacogn. 37: 103-109.
8 Jung, D. H., Kim, Y. S. and Kim, J. S. (2009) KIOM-79 prevents S100b-induced TGF-a1 and fibronectin expression in mouse mesangial cells. J. Ethnopharmacol. 125: 374-379.   DOI   ScienceOn
9 Vinson J. A. and Howard III T. B. (1996) Inhibition of protein glycation and advanced glycation endproducts by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7: 659-663.   DOI   ScienceOn
10 Jang, D. S., Lee, Y. M., Kim, Y. S. and Kim, J. S. (2006) Screening of Korean traditional herbal medicines with inhibitory activity on advanced glycation end products (AGEs) formation. Kor. J. Pharmacogn. 37: 48-52.
11 Lee, Y. M., Kim, Y. S., Kim, J. M., Jang, D. S., Kim, J. W., Yoo, J. L. and Kim, J. S. (2008) Screening of Korean herbal medicines with inhibitory activity on advanced glycation end products (AGEs) formation (II). Kor. J. Pharmacogn. 39: 223-227.
12 Kim, C.-S., Jang, D. S., Kim, J. H., Lee, G. Y., Lee, Y. M., Kim, Y. S. and Kim, J. S. (2008) Inhibitory effects of the seeds of Cornus officinalis on AGEs formation and AGEsinduced protein cross-linking. Kor. J. Pharmacogn. 39: 249-254.
13 Lee, G. Y., Jang, D. S., Lee, Y. M., Kim, Y. S. and Kim, J. S. (2008) Constituents of the seeds of Cornus officinalis with inhibitory activity on the formation of advanced glycation end products (AGEs). J. Korean Soc. Appl. Biol. Chem. 51: 316-320.   DOI
14 Sohn, E. J., Kim, Y. S., Kim, C.-S., Lee, Y. M. and Kim, J. S. (2009) KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice. J. Ethnopharmacol. 121:171-174.   DOI   ScienceOn
15 Jang, D. S., Kim, J. M., Lee, Y. M., Kim, Y. S., Kim. J.-H. and Kim, J. S. (2006) Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. 54: 1315-1317.
16 Brownlee, M. (2005) The Pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615-1625.   DOI   ScienceOn
17 Ahmed, N. (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21.   DOI   ScienceOn
18 Yokozawa, T., Nakagawa, T. and Terasawa, K. (2001) Effects of oriental medicines on the production of advanced glycation endproducts. J. trad. Med. 18: 107-112.
19 Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A. and Itoh, M. (1998) Effects of thyroid hormone on the sorbitol pathway in streptozotocininduced diabetic rats. Biochim. Biophys. Acta 1425: 577-586.   DOI   ScienceOn
20 Sakurai, T. and Tsuchiya, S. (1988) Superoxide production from nonenzymatically glycated protein. FEBS Lett. 236: 406-410.   DOI   ScienceOn
21 Bucala, R., Cerami, A. and Vlassara, H. (1995) Advanced glycosylation end products in diabetic complications. Diabetes Rev. 3: 258-268.
22 Hengel, A. J., Harkes, M. P., Wichers, H. J., Hesselink, P. G. M. and Buitelaar, R. M. (1992) Characterization of callus formation and camptothecin production by cell lines of Camptotheca acuminata. Plant Cell Tissue Organ. Cult. 28: 11-18.   DOI   ScienceOn
23 Larkins, R. G. and Dunlop, M. E. (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499-504.   DOI   ScienceOn
24 McCune, L. M. and Johns, T. (2002) Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the north american boreal forest. J. Ethnopharmacol. 82: 197-205.   DOI   ScienceOn
25 Ribaldo, P. D., Souza, D. S., Biswas, S. K., Block, K., Lopes de Faria, J. M. and Lopes de Faria, J. B. (2009) Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats. J. Nutr. 139: 96-100.